The glomerulus - a view from the inside - the endothelial cell

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 9, 2010, Pages 1388-1397

  Fogo, Agnes B ^a   Kon, Valentina ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Endothelial cell; Fibrosis; Glomerulus; Podocyte

Indexed keywords

CELL DAMAGE; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL REGENERATION; CELL STRUCTURE; DIABETIC NEPHROPATHY; ECLAMPSIA AND PREECLAMPSIA; ENDOTHELIUM INJURY; FIBROSIS; GLOMERULOPATHY; GLOMERULUS CAPILLARY; GLOMERULUS EPITHELIUM; GLYCOCALYX; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNE COMPLEX DISEASE; NONHUMAN; OBESITY; PODOCYTE; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SCLEROSIS; SHORT SURVEY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSPLANT GLOMERULOPATHY; ANIMAL; CYTOLOGY; ENDOTHELIUM CELL; GLOMERULUS; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; PODOCYTES;

EID: 77955097036     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.05.015     Document Type: Short Survey

References (133)

1. Adamczak M., Gross M.L., Amann K., Ritz E. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol 2004, 15:3063-3072.
2. Akis N., Madaio M.P. Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int 2004, 65:2223-2227.
3. Avasthi P.S., Koshy V. The anionic matrix at the rat glomerular endothelial surface. Anat Rec 1988, 220:258-266.
4. Baffert F., Le T., Thurston G., McDonald D.M. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol 2006, 290:H107-H118.
5. Ballermann B.J. Glomerular endothelial cell differentiation. Kidney Int 2005, 67:1668-1671.
6. Ballermann B.J. Contribution of the endothelium to the glomerular permselectivity barrier in health and disease. Nephron Physiol 2007, 106:19-25.
7. Bankston P.W., Milici A.J. A survey of the binding of polycationic ferritin in several fenestrated capillary beds: indication of heterogeneity in the luminal glycocalyx of fenestral diaphragms. Microvasc Res 1983, 26:36-48.
8. Benest A.V., Stone O.A., Miller W.H., Glover C.P., Uney J.B., Baker A.H., et al. Arteriolar genesis and angiogenesis induced by endothelial nitric oxide synthase overexpression results in a mature vasculature. Arterioscler Thromb Vasc Biol 2008, 28:1462-1468.
9. Bjornson A., Moses J., Ingemansson A., Haraldsson B., Sorensson J. Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their post-translational modification. Am J Physiol 2005, 288:F748-F756.
10. Bostrom M.A., Freedman B.I. The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol 2010, 5:1107-1113.
11. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992, 114:521-532.
12. Bulger R.E., Eknoyan G., Purcell D.J., Dobyan D.C. Endothelial characteristics of glomerular capillaries in normal, mercuric chloride-induced, and gentamicin-induced acute renal failure in the rat. J Clin Invest 1983, 72:128-141.
13. Campean V., Karpe B., Haas C., Atalla A., Peters H., Rupprecht H., et al. Angiopoietin 1 and 2 gene and protein expression Is differentially regulated in acute anti-Thy1.1 glomerulonephritis. Am J Physiol Renal Physiol 2008, 294:F1174-F1184.
14. Cao R., Brakenhielm E., Wahlestedt C., Thyberg J., Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 2001, 98:6390-6395.
15. Collino F., Bussolati B., Gerbaudo E., Marozio L., Pelissetto S., Benedetto C., et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008, 294:F1185-F1194.
16. Cook H.T. The origin of renal fibroblasts and progression of kidney disease. Am J Pathol 2010, 176:22-24.
17. D'Agati V., Yan S.F., Ramasamy R., Schmidt A.M. RAGE, glomerulosclerosis and proteinuria: Roles in podocytes and endothelial cells. Trends Endocrinol Metab 2010, 21:50-56.
18. Daniel T.O., Stein E., Cerretti D.P., St John P.L., Robert B., Abrahamson D.R. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int 1996, Suppl 57:S73-81.
19. Dilauro M., Burns K.D. Angiotensin-(1-7) and its effects in the kidney. Sci World J 2009, 9:522-535.
20. Drumond M.C., Deen W.M. Structural determinants of glomerular hydraulic permeability. Am J Physiol Renal Fluid Electrolyte Physiol 1994, 266:F1-F12.
21. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001, 108:1341-1348.
22. Eddy A.A., Fogo A.B. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 2006, 17:2999-3012.
23. Eitner F., Ostendorf T., Kretzler M., Cohen C.D., Eriksson U., Gröne H.J., et al. ERCB-Consortium. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J Am Soc Nephrol 2003, 14:1145-1153.
24. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111:707-716.
25. Eremina V., Baelde H.J., Quaggin S.E. Role of the VEGF - a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007, 106:32-37.
26. Eremina V., Jefferson J.A., Kowalewska J., Hochster H., Haas M., Weisstuch J., et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008, 358:1129-1136.
27. Ergonul Z., Clayton F., Fogo A.B., Kohan D.E. Shigatoxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol 2003, 18:246-253.
28. Fierlbeck W., Liu A., Coyle R., Ballermann B.J. Endothelial cell apoptosis during glomerular capillary lumen formation in vivo. J Am Soc Nephrol 2003, 14:1349-1354.
29. Floege J., Eitner F., Alpers C.E. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008, 19:12-23.
30. Fogo A., Breyer J.A., Smith M.C., Cleveland W.H., Agodoa L., Kirk K.A., et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK pilot study investigators. Kidney Int 1997, 51:244-252.
31. Fogo A.B. Progression versus regression of chronic kidney disease. Nephrol Dial Transplant 2006, 21:281-284.
32. Foster R.R., Satchell S.C., Seckley J., Emmett M.S., Joory K., Xing C.Y., et al. VEGF-C promotes survival in podocytes. Am J Physiol Renal Physiol 2006, 291:F196-F207.
33. Foster R.R., Slater S.C., Seckley J., Kerjaschki D., Bates D.O., Mathieson P.W., et al. Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium. Am J Pathol 2008, 173:938-948.
34. Fotheringham J., Angel C.A., McKane W. Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract. 2009, 113:c1-c7.
35. Freedman B.I., Hicks P.J., Bostrom M.A., Cunningham M.E., Liu Y., Divers J., et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 2009, 75:736-745.
36. Friedl J., Puhlmann M., Bartlett D.L., Libutti S.K., Turner E.N., Gnant M.F., et al. Induction of permeability across endothelial cell Monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 2002, 100:1334-1339.
37. Futrakul N., Butthep P., Laohareungpanya N., Chaisuriya P., Ratanabanangkoon K. A defective angiogenesis in chronic kidney disease. Ren Fail 2008, 30:215-217.
38. Gamble J.R., Drew J., Trezise L., Underwood A., Parsons M., Kasminkas L., et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000, 87:603-607.
39. Guo M., Ricardo S.D., Deane J.A., Shi M., Cullen-McEwen L., Bertram J.F. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat 2005, 207:813-821.
40. Hagele H., Allam R., Pawar R.D., Reichel C.A., Krombach F., Anders H.-J. Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. Am J Path 2009, 175:1896-1904.
41. Haraldsson B., Jeansson M. Glomerular filtration barrier. Curr Opin Nephrol Hypertens 2009, 18:331-335.
42. He P. Beyond tie-ing up endothelial adhesion: new insights into the action of angiopoietin-1 in regulation of microvessel permeability. Cardiovasc Res 2009, 83:1-2.
43. Henry C.B.S., Duling B.R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 1999, 277:H508-H514.
44. Henry C.B., Duling B.R. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000, 279:H2815-H2823.
45. Herman W.H., Emancipator S.N., Rhoten R.L., Simonson M.S. Vascular and glomerular expression of endothelin-1 in normal human kidney. Am J Physiol 1998, 275:F8-17.
46. Hirschberg R., Wang S., Mitu G.M. Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008, 331:485-493.
47. Hohenstein B., Hausknecht B., Boehmer K., Riess R., Brekken R.A., Hugo C.P. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006, 69:1654-1661.
48. Humphreys B.D., Lin S.-L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Path 2010, 176:85-97.
49. Hyslop S., de Nucci G. Vasoactive mediators released by endothelins. Pharmacol Res 1992, 26:223-242.
50. Ichimura K., Stan R.V., Kurihara H., Sakai T. Glomerular endothelial cells form diaphragms during development and pathologic conditions. J Am Soc Nephrol 2008, 19:1463-1471.
51. Ichinose K., Maeshima Y., Yamamoto Y., Kitayama H., Takazawa Y., Hirokoshi K., et al. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 2005, 54:2891-2903.
52. Ikoma M., Kawamura T., Kakinuma Y., Fogo A., Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991, 40:195-202.
53. Jaimes E.A., Hua P., Tian R.-X., Raij L. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol 2010, 298:F125-132.
54. Jarad G., Miner J.H. Update on the glomerular filtration barrier. Curr Opin Nephrol Hypertens 2009, 18:226-232.
55. Jeansson M., Haraldsson B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 2006, 291:F111-F116.
56. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784.
57. Kamba T., Tam B.Y., Hashizume H., Haskell A., Sennino B., Mancuso M.R., et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006, 290:H560-H576.
58. Kanasaki K., Kalluri R. The biology of preeclampsia. Kidney Int 2009, 76:831-837.
59. Kashihara N., Watanabe Y., Makino H., Wallner E.I., Kanwar Y.S. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA 1992, 89:6309-6313.
60. Karet F.E., Kuc R.D., Davenport A.P. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int 1993, 44:36-42.
61. Kuo M.C., Patschan D., Patschan S., Cohen-Gould L., Park H.C., Ni J., et al. Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells. J Am Soc Nephrol 2008, 19:2321-2330.
62. Lebrin F., Deckers M., Bertolino P., Ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovasc Res 2005, 65:599-608.
63. Lely A.T., Hamming I., van Goor H., Navis G.J. Renal ACE2 expression in human kidney disease. J Pathol 2004, 204:587-593.
64. Li J., Qu X., Bertram J.F. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 2009, 175:1380-1388.
65. Li X., Tjwa M., Moons L., Fons P., Noel A., NyA, et al. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J Clin Invest 2005, 115:118-127.
66. Liang X.B., Ma L.J., Naito T., Wang Y., Madaio M., Zent R., et al. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J Am Soc Nephrol 2006, 17:1886-1895.
67. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000, 105:71-77.
68. Lin C.X., Rhaleb N.E., Yang X.P., Liao T.D., D'Ambrosio M.A., Carretero O.A. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 2008, 295:H1253-H1261.
69. Ma L.J., Nakamura S., Aldigier J.C., Rossini M., Yang H., Liang X., et al. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005, 16:966-976.
70. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
71. Menke J., Zeller G.C., Kikawada E., Means T.K., Huang X.R., Lan H.Y., et al. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J Am Soc Nephrol 2008, 19:1177-1189.
72. Miyamoto K., Kitamoto Y., Tokunaga H., Takeya M., Ezaki T., Imamura T., et al. Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab Invest 2004, 84:1126-1136.
73. Moake J.L. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Hematol 2004, 41:4-14.
74. Nagao T., Matsumura M., Mabuchi A., Ishida-Okawara A., Koshio O., Nakayama T., et al. Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody. Nephrol Dial Transplant 2007, 22:77-87.
75. Nambi P., Pullen M., Wu H.L., Aiyar N., Ohlstein E.H., Edwards R.M. Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 1992, 131:1081-1086.
76. Navar L.G. Glomerular permeability: a never-ending saga. Am J Physiol Renal Physiol 2009, 296:F1266-F1268.
77. Neal C.R., Crook J., Bell E., Harper S.J., Bates D.O. Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space. J Am Soc Nephrol 2005, 16:1223-1235.
78. Nestoridi E., Kushak R.I., Tsukurov O., Grabaowski E.F., Ingelfinger J.R. Role of the renin angiotensin system in TNF- alpha and Shiga-toxin-induced tissue factor expression. Pediatr Nephrol 2008, 23:221-231.
79. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009, 361:1676-1687.
80. Notoya M., Shinosaki T., Kobayashi T., Sakai T., Kurihara H. Intussusceptive capillary growth is required for glomerular repair in rat Thy-1.1 nephritis. Kidney Int 2003, 63:1365-1373.
81. Nyengaard J.R., Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 1993, 36:189-194.
82. Nystrom J., Fierlbeck W., Granqvist A., Kulak S.C., Ballermann B.J. A human glomerular SAGE transcriptome database. BMC Nephrol 2009, 10:13.
83. Ott M.J., Olson J.L., Ballermann B.J. Phenotypic differences between glomerular capillary and aortic endothelial cells in vitro (abstract). J Am Soc Nephrol 1993, 4:564A.
84. Pala L., Cresci B., Manuelli C., Maggi E., Yamaguchi Y.F., Cappugi P., et al. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: biological effects and advanced glycosilation end products modulation. Microvasc Res 2005, 70:179-188.
85. Panzer U., Steinmetz O.M., Reinking R.R., Meyer T.N., Fehr S., Schneider A., et al. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 2006, 17:454-464.
86. Panzer U., Steinmetz O.M., Paust H.J., Meyer-Schwesinger C., Peters A., Turner J.E., et al. Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol 2007, 18:2071-2084.
87. Quaggin S.E., Kreidberg J.A. Development of the renal glomerulus: good neighbors and good fences. Development 2008, 135:609-620.
88. Qiu Y., Hoareau-Aveilla C., Oltean S., Harper S.J., Bates D.O. The anti-angiogenic isoforms of VEGF in health and disease. Biochem Soc Trans 2009, 37(Pt 6):1207-1213.
89. Ranieri G., Patruno R., Ruggieri E., Montemurro S., Valerio P., Ribatti D. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem 2006, 13:1845-1857.
90. Rizkalla B., Forbes J.M., Cao Z., Boner G., Cooper M.E. Temporal renal expression of angiogenic growth Factors and their receptors in experimental diabetes: role of the renin-angiotensin system. J Hypertens 2005, 23:153-164.
91. Robert B., St John P.L., Hyink D.P., Abrahamson D.R. Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 1996, 271:F744-F753.
92. Robert B., Zhao X., Abrahamson D.R. Coexpression of neuropilin-1, Flk1, and VEGF (164) in developing and mature mouse kidney glomeruli. Am J Physiol Renal Physiol 2000, 279:F275-F282.
93. Rookmaaker M.B., Smits A.M., Tolboom H., Van't Wout K., Martens A.C., Goldschmeding R., et al. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol 2003, 163:553-562.
94. Rossini M., Cheunsuchon B., Donnert E., Ma L.J., Thomas J.W., Neilson E.G., et al. Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int 2005, 68:2621-2628.
95. Salmon A.H., Toma I., Sipos A., Muston P.R., Harper S.J., Bates D.O., et al. Evidence for restriction of fluid and solute movement across the glomerular capillary wall by the subpodocyte space. Am J Physiol Renal Physiol 2007, 293:F1777-F1786.
96. Salmon A.H.J., Neal C.R., Harper S.J. New aspects of glomerular filtration barrier structure and function: five layers (at least) not three. Curr Opin Nephrol Hypertens 2009, 18:197-205.
97. Salmon A.H.J., Neal C.R., Sage L.M., Glass C.A., Harper S.J., Bates D.O. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res 2009, 83:24-33.
98. Santos R.A., Brosnihan K.B., Jacobsen D.W., DiCorleto P.E., Ferrario C.M. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension 1992, 19:II56-61.
99. Satchell S.C., Anderson K.L., Mathieson P.W. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol 2004, 15:566-574.
100. Satchell S.C., Tasman C.H., Singh A., Ni L., Geelen J., von Ruhland C.J., et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 2006, 69:1633-1640.
101. Satchell S.C., Tooke J.E. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?. Diabetologia 2008, 51:714-725.
102. Satchell S.C., Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 2009, 296:F947-F956.
103. Segal M.S., Baylis C., Johnson R.J. Endothelial health and diversity in the kidney. J Am Soc Nephrol 2006, 17:323-324.
104. Segerer S., Henger A., Schmid H., Kretzler M., Draganovici D., Brandt U., et al. Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int 2006, 69:1765-1773.
105. Shimizu A., Masuda Y., Mori T., Kitamura H., Ishizaki M., Sugisaki Y., et al. Vascular endothelial growth factor 165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 2004, 15:2655-2665.
106. Singh A., Satchell S.C., Neal C.R., McKenzie E.A., Tooke J.E., Mathieson P.W. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007, 18:2885-2893.
107. Sorensson J., Fierlbeck W., Heider T., Schwarz K., Park D.S., Mundel P., et al. Glomerular endothelial fenestrae in vivo are not formed from caveolae. J Am Soc Nephrol 2002, 13:2639-2647.
108. Takamatsu M., Urushihara M., Kondo S., Shimizu M., Morioka T., Oite T., et al. Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol 2008, 23:1257-1267.
109. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
110. Tischer E., Gospodarowicz D., Mitchell R., Silva M., Schilling J., Lau K., et al. Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989, 165:1198-1206.
111. Toma I., Kang J.J., Sipos A., Vargas S., Bansal E., Hanner F., et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 2008, 118:2526-2534.
112. Toyoda M., Najafian B., Kim Y., Caramori M.L., Mauer M. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007, 56:2155-2160.
113. Tsai H.M. The molecular biology of thrombotic microangiopathy. Kidney Int 2006, 70:16-23.
114. Vasile E., Qu H., Dvorak H.F., Dvorak A.M. Caveolae and vesiculovacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels. J Histochem Cytochem 1999, 47:159-167.
115. Vasmant D., Maurice M., Feldmann G. Cytoskeleton ultrastructure of podocytes and glomerular endothelial cells in man and in the rat. Anat Rec 1984, 210:17-24.
116. Vaughan M.R., Quaggin S.E. How do mesangial and endothelial cells form the glomerular tuft?. J Am Soc Nephrol 2008, 19:24-33.
117. Velez J.C., Bland A.M., Arthur J.M., Raymond J.R., Janech M.G. Characterization of renin angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007, 293:F398-407.
118. Vielhauer V., Stavrakis G., Mayadas T.N. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005, 115:1199-1209.
119. Vink H., Duling B.R. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 1996, 79:581-589.
120. Wang G., Cai S., Deng X., Ouyang K., Xie G., Guidoin R. Secretory response of endothelin-1 in cultured human glomerular microvascular endothelial cells to shear stress. Biorheology 2000, 37:291-299.
121. Wang S., deCaestecker M., Kopp J., Mitu G., Lapage J., Hirschberg R. Renal bonemorphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 2006, 17:2504-2512.
122. Wendel M., Knels L., Kummer W., Kocj T. Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney. J Histochem Cytochem 2006, 54:1193-1203.
123. Wolf G., Chen S., Ziyadeh F.N. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005, 54:1626-1634.
124. Woolf A.S., Gnudi L., Long D.A. Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 2009, 20:239-244.
125. Woolf A.S. Angiopoietins: vascular growth factors looking for roles in glomeruli. Curr Opin Nephrol Hypertens 2010, 19:20-25.
126. Xu B.J., Shyr Y., Liang X., Ma L.J., Donnert E.M., Roberts J.D., et al. Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol 2005, 16:2967-2975.
127. Yamaguchi Y., Iwano M., Suzuki D., Nakatani K., Kimura K., Harada K., et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 2009, 54:653-664.
128. Yamamoto Y., Maeshima Y., Kitayama H., Kitamura S., Takazawa Y., Sugiyama H., et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004, 53:1831-1840.
129. Yang X., Smith U. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?. Diabetologia 2007, 50:1127-1139.
130. Ye M., Wysocki J., William J., Soler M.J., Cokic I., Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006, 17:3067-3075.
131. Yoshioka T., Ichikawa I., Fogo A. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 1991, 2:902-912.
132. Yuan H.T., Tipping P.G., Li X.Z., Long D.A., Woolf A.S. Angiopoietin correlates with glomerular capillary loss in antiglomerular basement membrane glomerulonephritis. Kidney Int 2002, 61:2078-2089.
133. Zhao H.J., Wang S., Cheng H., Zhang M.Z., Takahashi T., Fogo A.B., et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006, 17:2664-2669.